Dahlquist Karl S.
Known title: Chief Legal OfficerCIK: 0001861996
Associated companies
Transaction History
| ATRC | ▼ Sell | Open Market | 9,370 | $458K | 8/24/2026 | View on chart |
| ATRC | ▲ Buy | Grant | 636 | $15K | 6/30/2026 | View on chart |
| ATRC | ▲ Buy | Grant | 27,991 | $0 | 3/1/2026 | View on chart |
| ATRC | ▲ Buy | Grant | 15,198 | $0 | 3/1/2026 | View on chart |
| ATRC | ▼ Sell | Tax Withholding | 15,687 | $490K | 3/1/2026 | View on chart |
| ATRC | ▲ Buy | Grant | 822 | $21K | 6/30/2025 | View on chart |
| ATRC | ▼ Sell | Tax Withholding | 9,870 | $382K | 3/1/2025 | View on chart |
| ATRC | ▲ Buy | Grant | 19,359 | $0 | 3/1/2025 | View on chart |
| ATRC | ▲ Buy | Grant | 6,579 | $0 | 3/1/2025 | View on chart |
| ATRC | ▲ Buy | Grant | 707 | $14K | 6/28/2024 | View on chart |
| ATRC | ▼ Sell | Open Market | 1,885 | $61K | 3/18/2024 | View on chart |
| ATRC | ▼ Sell | Open Market | 8,231 | $308K | 3/5/2024 | View on chart |
| ATRC | ▲ Buy | Grant | 22,050 | $0 | 3/1/2024 | View on chart |
| ATRC | ▲ Buy | Grant | 8,231 | $0 | 3/1/2024 | View on chart |
| ATRC | ▼ Sell | Open Market | 1,248 | $43K | 11/1/2023 | View on chart |
| ATRC | ▼ Sell | Open Market | 3,417 | $195K | 7/26/2023 | View on chart |
| ATRC | ▲ Buy | Grant | 557 | $21K | 6/30/2023 | View on chart |
| ATRC | ▼ Sell | Open Market | 1,422 | $67K | 6/6/2023 | View on chart |
| ATRC | ▼ Sell | Open Market | 4,417 | $198K | 5/1/2023 | View on chart |
| ATRC | ▼ Sell | Tax Withholding | 6,894 | $268K | 3/1/2023 | View on chart |
| ATRC | ▲ Buy | Grant | 8,036 | $0 | 3/1/2023 | View on chart |
| ATRC | ▲ Buy | Grant | 16,104 | $0 | 3/1/2023 | View on chart |
| ATRC | ▲ Buy | Grant | 350 | $12K | 6/30/2022 | View on chart |
| ATRC | ▼ Sell | Tax Withholding | 7,299 | $508K | 3/1/2022 | View on chart |
| ATRC | ▲ Buy | Grant | 6,825 | $0 | 3/1/2022 | View on chart |
| ATRC | ▲ Buy | Grant | 7,789 | $0 | 3/1/2022 | View on chart |
| ATRC | ▲ Buy | Grant | 24 | $1K | 12/31/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
BTIG raises AtriCure price target to $63
BTIG raised its price target on AtriCure to $63. The new target sits above the current analyst consensus of $54.89 and exceeds the stock’s recent 52‑week high of $61.70. This adjustment may influence market expectations as the company trades near its recent support level of $27.47.
BTIG raises AtriCure price target to $63. BTIG raised its price target on AtriCure to $63. The new target sits above the current analyst consensus of $54.89 and exceeds the stock’s recent 52‑week high of $61.70. This adjustment may influence market expectations as the company trades near its recent support level of $27.47.